Ben Lamm, Biotech & Health, Colossal Biosciences, de-extinction tech, Startups, Tech, Tech News

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

/

The de-extinction startup is looking to double or triple its previous valuation, according to the report.